1/21
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
General lifetime risk of cancer in the US?
specifically:
Prostate (men only)
Breast
- women
-men
Lung & bronchus (both sexes)
CRC (both sexes)
Uterine
Ovarian
1/3 women
1/2 men
rates: depend on age, race, and geography
Prostate (men only): 1/8
Breast
- women: 1/8
-men: 1/1000
Lung & bronchus (both sexes): 1/16
CRC (both sexes): 1/24
Uterine: 1/32
Ovarian: 1/87
What are the most to the least common cancers for adult men (AMAB)?
Prostate
Lung
CRC
Urinary
What are the most to the least common cancers for adult women (AFAB)?
Breast
Lung
CRC
Uterine
What are the most to the least common cancers for children?
Leukemia
Brain/CNS
Soft tissue
Non-Hodgkin Lymphoma
What ranking is for the leading cause of death (adults & kids)?
2nd leading COD for all ages. 4th for adults and 2nd for kids
Most to least common cancer deaths for adult men (AMAB)?
Lung
Prostate
CRC
Most to least common cancer deaths for adult women (ADAB)?
Lung
Breast
CRC
What are the general five-year survival rates for:
Prostate
Breast
CRC
Lung
Pancreatic
Prostate- 100%
Breast- 89%
CRC- 65%
Lung- 16%
Pancreatic- 4%
What are the median ages of cancer for (should know generally):
NEED TO KNOW:
All
CRC
Uterine
Ovary
Breast
Prostate
Should know:
Lung
Pancreatic
Leukemia
- ALL
-AML
Renal
Cervix
Thyroid
Hodgkin lymphoma
Testis
NEED TO KNOW:
All- 67y
CRC -72y
Uterine- 63y
Ovary- 63y
Breast- 61y
Prostate- 68y
Should know:
Lung- 70y
Pancreatic- 72
Leukemia- 68y
- ALL- 12y
-AML- 68y
Renal- 65y
Cervix - 47y
Thyroid - 46y
Hodgkin lymphoma- 37y
Testis- 34y
What are the recommended cancer screening for population?
Br
CRC
Cervical
Uterine
Prostate
Ovarian
Br:
- 40y or older: Annual mammogram and clinical encounter
- 25-39y: clinical encounter every 1-3y
- Breast density impacts screening: ex. 6-12m/o for clinical encounters, extremely dense recommended MRI)
CRC: starts at 45y
- cscope every 10yrs (if no polyps)
- flexible sigmoidoscopy every 5yrs
methods that cannot remove anything:
- double contrast barium enema every 5 yrs
-CT colography (virtual colonoscopy) every 5yrs
Cervical:
- 21-29y: papsmear every 3 yrs
- 30-65: papsmear and HPV test every 5yrs
- >65y: no screening unless hx of cancer/pre-cancer
Uterine: based on p/fhx
Prostate: individual decision to screen or not. PSA (blood test)/ rectal exam at 50y
Ovarian: no agreed-upon screening
What questions are always important to ask?
current ages
age of dx of ca and age at death
surgical hx of unaffected individuals
laterality of tumors in paired organs like breast
Environmental factors (like geographics w/ skin cancers)
Bonus:
- death/pathology/medical records
- tx modes
- confirm differences in types of cancers like cervical vs uterine
common pedigree pitfalls
history more accurate when patient is affected
br and colon have better accuracy than ov, endometrial, and prostate cancer. ex: "female ca"
not all skin ca are melanomas
Beware of metastatic spread
Truncated family history
What cancer types are common metastatic spread (like a secondary)?
Brain- primary ca usually lung, breast, melanoma, renal-cell, CRC
Lung- primary ca usually renal-cell, CRC, melanoma, breast, sarcoma
Liver- primary ca usually CRC, pancreatic, breast, lung, stomach
Bone- primary ca usually breast, lung, prostate, renal-cell, CRC,
what are some clues to hereditary cancer syndromes?
ca in 2 or more close relatives in same lineage
earlier onset age
multiple primary tumors
tumors types consistent w known syndrome like breast and ovarian or colon and uterine
cancer in every generation
abnormal tumor markers: triple negative breast ca or absence of MSH2 by IHC
What factors impact penetrance?
modifier genes
environmental factors/lifestyle: smoking, EtOH, asbestos
response to DNA damage (b/c of modifier genes)
Reproductive/hormonal factors like HRT
Genotype (what type of mutation)
How does translocation impact cancer? what category of genes is it?
chromosomal translocations can activate a proto-oncogene
most translocations are specific to certain tumors
often occur in hematologic cancers
- Philadelphia chromosome in CML (one of if not the most common)-> 9;22 translocation combines 2 proto-oncogenes
germline mutations that increase cancer tend to be proto-oncogenes or tumor suppressor genes? are there any exceptions
germline oncogene mutations are rare -> could be lethal in development. if all cells grow then causes problems. Missense mutations, amplification, promoter alterations common. nonsense and frameshift not.
EXCEPTIONS:
ALK gene- hereditary neuroblastoma
MET gene- hereditary papillary renal cell cancer
RET gene- multiple endocrine neoplasia
what is a DCIS and what does it mean? vs LCIS?
DCIS: stage 0 "ca", tx: surgery +/- XRT
LCIS: 90% premenopausal women, often multifocal and bilateral (85% & 30% respectively), and a marker of risk b/c risk is 7-18x higher, applies to both breasts, 10-year risk at least 7%, and can get lobular and ductal ca. tx: surgery only
- subsection of Pleomorphic LCIS: which is higher grade, more typical of DCIS, and no provider consensus
What are the common clinical presentations of ut/ov? ca?
suspicious of abdominal/pelvic mass in physical exam
abd bloating and/or distention
Ascites
abd pain
vaginal bleeding (POSTMENOPAUSAL IS HUGE RED FLAG)
incidental findings
screening for ut and/or ov ca?
transvaginal ultrasound w color doppler flow
CA-125-> transducer blood marker test which can INDICATE getting screening. high false +
- CT/MRI/PET
What is cancer grading? how does it work
Determines extent to which tumor resembles normal tissue and indicates likely metastasis rate
Grade doesn't typically change but can(?)
Gx: cant be assessed so undetermined
G1: ca look like normal cells and usually slow growing. low grade/well differentiated
G2: don't resemble normal cells but appear to stick together and grow faster. intermediate/moderate grade or moderately differentiated
G3: irregular shapes, stick together, and fast growing. high grade or poorly differentiated
G4: undifferentiated. little to no similarity to normal tissue.
What is cancer staging? how does it work
predicts the severity of cancer based on: location of tumor, tumor size & extent of tumor, lymph node involvement, presence or absence of metastasis.
Does not change. just get more info added.
TNM system:
T= tumor size & extent of tumor. TX= no eval, T0= in situ, T1=localized, T2 = early locally advanced, T3= Late locally advanced, t4= metastasis.
- T SYSTEM IS DIFFERENT IN HEMATOLOGIC CANCERS
N= nodal involvement. NX, N1-3
M= Metastases. MX, M0= none, M1= yes